Table I.
(PML cases/HIV-positive controls) |
|||||||
---|---|---|---|---|---|---|---|
JCV/BKV outcome | No. pairs | (Nea/Neft) | (Pos/Pos) | (Pos/Neg) | (Nep/Pos) | MOR* (95%CI) | |
JCV Viruria | |||||||
Viruria at any visit** | 26 | 11 | 5 | 4 | 6 | 0.7 (0.1 – 2.8) | |
Transient Viruria† | 26 | 20 | 1 | 0 | 5 | - | |
Persistent Viruria† | 26 | 17 | 1 | 6 | 2 | 3 (0.5 – 30.4) | |
BKV Viruria | |||||||
Viruria at any visit** | 26 | 18 | 0 | 3 | 5 | 0.6 (0.1 – 3.1) |
Matched odds ratio and 95% confidence interval
JCV and BKV viruria at any visit defined as presence of JCV or BKV viruria at either visits 1,2 or 3
Persistent viruria defined as two or more consecutive visits with JCV Viruria; transient viruria defined as Viruria at one or more non-consecutive visits.